Myriad Genetics (MYGN) Prepaid Assets (2010 - 2026)

Myriad Genetics has disclosed Prepaid Assets across 17 years of filings, most recently posting $34.7 million for Q1 2026.

• In Q1 2026, Prepaid Assets rose 142.66% year-over-year to $34.7 million; the TTM figure through Mar 2026 stood at $34.7 million (up 142.66% YoY), while the FY2025 annual figure was $12.0 million, down 26.83% from the prior year.
• Prepaid Assets improved to $34.7 million in Q1 2026, from $12.0 million in the prior quarter.
• Over the last five years, Prepaid Assets for MYGN reached as high as $34.7 million in Q1 2026 and fell as low as $12.0 million in Q4 2025.
• The 5-year median for Prepaid Assets is $18.8 million (2022), against an average of $19.5 million.
• Annual changes were most pronounced in 2022 — Prepaid Assets soared 4775.0% — and 2025, when it plunged 43.44%.
• A 5-year view of Prepaid Assets shows it stood at $20.4 million in 2022, then decreased by 4.9% to $19.4 million in 2023, then decreased by 15.46% to $16.4 million in 2024, then retreated by 26.83% to $12.0 million in 2025, then soared by 189.17% to $34.7 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $34.7 million, $12.0 million, and $13.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.